Literature DB >> 30328617

Characterizing the three-dimensional organization of telomeres in papillary thyroid carcinoma cells.

Paola Caria1, Tinuccia Dettori1, Daniela Virginia Frau1, Daniel Lichtenzstejn2, Fabiana Pani3, Roberta Vanni1, Sabine Mai2.   

Abstract

The relationship between the three-dimensional (3D) nuclear telomere architecture and specific genetic alterations in papillary thyroid carcinoma (PTC), in particular in cancer stem-like cells (CSLCs), has not yet been investigated. We isolated thyrospheres containing CSLCs from B-CPAP, K1, and TPC-1 PTC-derived cell lines, representative of tumors with different genetic backgrounds within the newly identified BRAFV600E -like PTC subgroup, and used immortalized normal human thyrocytes (Nthy-ori 3.1) as control. We performed quantitative fluorescence in situ hybridization, 3D imaging, and 3D telomere analysis using TeloView software to examine telomere dysfunction in both parental and thyrosphere cells. Among the 3D telomere profile, a wide heterogeneity was observed, except for telomere intensity. Our findings indicate that CSLCs of each cell line had longer telomeres than parental cells, according to telomere intensity values, which correlate with telomere length. Indeed, the thyrosphere cells had lower numbers of lower-intensity telomeres (≤5,000 arbitrary fluorescent units, a.u.), compared with parental cancer cells, as well as parental control cells, (p < 0.0001). The B-CPAP thyrospheres showed a decreased number of higher intensity telomeres (>17,000 a.u.) than K1 and TPC-1 cells, as well as control cells (p < 0.0001). By selecting PTC-derived cell lines with different genetic backgrounds characteristic of BRAFV600E -like PTC subgroups, we demonstrate that thyrosphere cells with BRAFV600E and TP53 mutations show shorter telomeres than those harboring RET/PTC or BRAFV600E and wild-type TP53. Hence, our data reveal a trend towards a decrease in telomere shortening in CSLCs, representing the early cancer-promoting subpopulation, as opposed to parental cells representing the tumor bulk cells.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  3D quantitative nuclear telomere analysis; cancer stem-like cells; papillary thyroid carcinoma; quantitative fluorescence in situ hybridization

Mesh:

Substances:

Year:  2018        PMID: 30328617     DOI: 10.1002/jcp.27321

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Extra-telomeric impact of telomeres: Emerging molecular connections in pluripotency or stemness.

Authors:  Soujanya Vinayagamurthy; Akansha Ganguly; Shantanu Chowdhury
Journal:  J Biol Chem       Date:  2020-05-22       Impact factor: 5.157

2.  Three-dimensional telomere profiles in papillary thyroid cancer variants: A pilot study.

Authors:  Aline Rangel-Pozzo; Tinuccia Dettori; Daniela Virginia Frau; Federica Etzi; John Gartner; Garbor Fisher; Roberta Vanni; Sabine Mai; Paola Caria
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

3.  Metabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study.

Authors:  Paola Caria; Laura Tronci; Tinuccia Dettori; Federica Murgia; Maria Laura Santoru; Julian L Griffin; Roberta Vanni; Luigi Atzori
Journal:  Int J Mol Sci       Date:  2018-09-27       Impact factor: 5.923

4.  Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy.

Authors:  Landon Wark; Harvey Quon; Aldrich Ong; Darrel Drachenberg; Aline Rangel-Pozzo; Sabine Mai
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

Review 5.  The Immune Landscape of Papillary Thyroid Cancer in the Context of Autoimmune Thyroiditis.

Authors:  Fabiana Pani; Paola Caria; Yoshinori Yasuda; Miyara Makoto; Stefano Mariotti; Laurence Leenhardt; Solmaz Roshanmehr; Patrizio Caturegli; Camille Buffet
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

6.  Analysis of the Mechanism of Maslinic Acid on Papillary Thyroid Carcinoma Based on RNA-Seq Technology.

Authors:  Rong Li; Yanjiao Zhang; Runqing Xiang; Aihe Lin; Zongxiao Xia; Xiaomei Long; Shuang Guo; Yuan Fan; Zukun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-07       Impact factor: 2.650

7.  Vitamin C Cytotoxicity and Its Effects in Redox Homeostasis and Energetic Metabolism in Papillary Thyroid Carcinoma Cell Lines.

Authors:  Laura Tronci; Gabriele Serreli; Cristina Piras; Daniela Virginia Frau; Tinuccia Dettori; Monica Deiana; Federica Murgia; Maria Laura Santoru; Martina Spada; Vera Piera Leoni; Julian Leether Griffin; Roberta Vanni; Luigi Atzori; Paola Caria
Journal:  Antioxidants (Basel)       Date:  2021-05-20

8.  Methylation of Subtelomeric Chromatin Modifies the Expression of the lncRNA TERRA, Disturbing Telomere Homeostasis.

Authors:  Diego Oliva-Rico; Eunice Fabian-Morales; Rodrigo E Cáceres-Gutiérrez; Adriana Gudiño; Fernanda Cisneros-Soberanis; Julieta Dominguez; Oscar Almaraz-Rojas; Cristian Arriaga-Canon; Clementina Castro-Hernández; Carlos De la Rosa; José L Reyes; Luis A Herrera
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.